Zhuhai Yufan Biotechnologies Co., Ltd

This early-stage study tests a new drug called PRJ1-3024 in about 39 adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the right dose. Researchers will also look for signs that the drug migh…